This new 271-page report from VPGMarketResearch.com provides a comprehensive analysis in the Spanish endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.
During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.
Contains 271 pages and 18 tables
SIMILAR MARKET STUDIES
2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Technology Trends, Opportunities for Suppliers
This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the ...
October 2016 | $0 | View Details >>
Notes: Sales, means the sales volume of Plasma Therapy Revenue, means the sales value of Plasma Therapy This report studies sales (consumption) of Plasma Therapy in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering BioLife Plasma Services (U.S.) Cambryn Biologics LLC (U.S.) Biotest ...
August 2016 | $3800 | View Details >>
2015-2019 France Hepatitis Diagnostics Market: Emerging Opportunities for Suppliers-Hospitals, Blood Banks, Commercial Labs-Competitive Strategies, Supplier Shares, Market Segment Forecastsfor Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs ...
July 2015 | $2500 | View Details >>
This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
November 2014 | $350 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research